Fabius- Once IPCI starts showing a consistent profit. Hopefully the standard P/E can be applied to them. Or at least something close :-)
1. First thing we need is Seroquel approval and commercialization. 2. Next, we need PAR to announce the release of remaining Focalin doses. 3. Pray for Pristiq and/or Lamictal approval. My guess is this will add about $2-3M per quarter but it would go straight to profit. 4. Gluco partner hopefully happens as well. That would be a nice adder to bottom line too. Not a lot of revenue because of off shore competition and low margins... But it would at least be something.
The Rexista lawsuit will drag on(I believe it is a stall tactic)... I am not expecting much on that front this year. But I am hoping IPCI can at least get profitable in 2017 and put dilution worries behind for good.